BioAura LabsResearch Vials
PEPTIDE BLENDS BIOAURA LABS
Klow Blend
Four constituents. A clearly defined research blend.
GHK-Cu, BPC-157, TB-500, and KPV. Four listed constituents in an 80 mg vial presentation for laboratory research.
For laboratory research use only.
Not for human or veterinary use.
80 mg · Vials
SELECT YOUR PRESENTATION Catalog preview
TECHNICAL OVERVIEW
Four constituents. A clearly defined research blend.
A multi-component blend creates a distinct analytical problem: each constituent needs to be identified and quantified within the finished preparation. The supplied constituent list provides a starting composition, while lot-specific results are needed to verify what is actually present.
The ingredients appear in different biochemical research contexts. Their inclusion in one vial does not demonstrate synergy, compatibility, enhanced activity, or a predictable cellular response. The exact TB-500 identity and the characterization of the copper-peptide component are particularly important for comparison.
GHK-Cu50 mg
BPC-15710 mg
TB-50010 mg
KPV10 mg
Supplied catalog composition; finished-blend identity and amounts require verification.
RESEARCH CONTEXT
Multi-peptide compatibility and stability investigation
Comparative characterization of a defined blend
Specifications
- Catalog identity
- Klow Blend
- Research classification
- Research peptide blend · Four components
- Available presentations
- 80 mg · Vials
- Intended use
- For laboratory research use only. Not for human or veterinary use. Not for consumption or administration.
- Quantity interpretation
- Listed amounts identify catalog presentations, not doses. Confirm the content basis in the supplier specification.
- Identity and formulation
- Verification of all four constituent identities and amounts, exact TB-500 sequence, copper-complex specification, and finished-blend analysis.
- Lot-specific analytical results
- Pending. No purity, potency, sterility, endotoxin, or third-party testing claim is verified for this preview.
- Storage and stability
- Pending supplier instructions. No storage temperature, shelf life, or opened-container period is assigned.
Documentation & material status
Lot-specific records have not been supplied for this preview. Product imagery and general research literature do not establish the properties of a BioAura lot.
SPECTechnical specificationPending supplier verification
Verification of all four constituent identities and amounts, exact TB-500 sequence, copper-complex specification, and finished-blend analysis.
COACertificate of analysisLot-matched COA pending
Review the matching lot identifier, analytical methods, acceptance criteria, measured results, units, and issuing laboratory. A purity percentage alone does not establish content, identity, or suitability.
SDSSafety & handling recordsSupplier documentation pending
Obtain the relevant safety data, handling precautions, storage conditions, stability information, and disposal requirements before laboratory work.
PRODUCT QUESTIONS
Frequently Asked Questions
What makes up the listed 80 mg total?
The supplied list states GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg. These are declared catalog amounts, not verified lot results.
What does the listed presentation tell me?
80 mg · Vials. These are supplied catalog details. They do not specify an experimental concentration, dose, preparation procedure, or administration instruction.
Is this intended for human or veterinary use?
For laboratory research use only. Not for human or veterinary use. Not for consumption or administration. This page provides no treatment, dosing, reconstitution, or administration guidance.
Can I purchase through this preview?
No. Prices and shopping-bag interactions demonstrate the proposed store experience. Final prices, availability, shipping, and payment processing have not been activated.
CONTINUE EXPLORING